Amisulpride
CAS number： 71675-85-9
Molecular formula： C17H27N3O4S
molecular weight： 369.48
Chemical structure：
Producers shown on SFDA
(Record date:07/09/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
| Qilu Antibiotics (Linyi) Pharmaceutical Co., Ltd. | GMP | Valid till November 2020 |
Producers shown on EP
(Quoted from EP website；record date:07/09/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Amisulpride | SUN PHARMACEUTICAL INDUSTRIES LIMITED IN 400 063 Mumbai | R1-CEP 2009-246-Rev 01 | 01/07/2016 | WITHDRAWN BY HOLDER | 12/07/2021 | Chemistry |
| Amisulpride | HUBEI HAOSUN PHARMACEUTICAL CO., LTD. CN 436 070 Ezhou | R1-CEP 2009-342-Rev 03 | 31/01/2020 | VALID | / | Chemistry |
| Amisulpride | SANOFI CHIMIE FR 94250 Gentilly | R1-CEP 2002-208-Rev 07 | 07/08/2019 | VALID | / | Chemistry |
| Amisulpride Process-2 | SYMED LABS LIMITED IN 500 034 Hyderabad | R0-CEP 2019-147-Rev 00 | 15/10/2020 | VALID | / | Chemistry |
| Amisulpride | SYMED LABS LIMITED IN 500 034 Hyderabad | R1-CEP 2010-185-Rev 01 | 21/02/2019 | VALID | / | Chemistry |
| Amisulpride Process II | SUN PHARMACEUTICAL INDUSTRIES LIMITED IN 400 063 Mumbai | R0-CEP 2016-028-Rev 01 | 25/02/2019 | VALID | / | Chemistry |
| Amisulpride | ICROM S.R.L. IT 20863 Concorezzo | R1-CEP 2009-215-Rev 02 | 16/06/2021 | VALID | / | Chemistry |
| Amisulpride Finorga S.A.S | SANOFI CHIMIE FR 94250 Gentilly | R0-CEP 2019-265-Rev 00 | 26/03/2020 | VALID | / | Chemistry |
| Amisulpride | Cosma S.p.A. IT 24040 Ciserano | R1-CEP 2009-397-Rev 01 | 24/08/2017 | VALID | / | Chemistry |
| Amisulpride | Erregierre S.p.A. IT 24060 San Paolo D'Argon | R1-CEP 2008-202-Rev 03 | 06/12/2017 | VALID | / | Chemistry |
| Amisulpride | Laboratorios Espinos Y Bofill S.A. (LEBSA) ES 08940 Cornellà | R1-CEP 2003-099-Rev 03 | 02/09/2019 | VALID | / | Chemistry |
| Amisulpride | AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad | R1-CEP 2010-005-Rev 03 | 24/07/2018 | VALID | / | Chemistry |
| Amisulpride Process 2 | ICROM S.R.L. IT 20863 Concorezzo | R0-CEP 2019-051-Rev 02 | 30/03/2021 | VALID | / | Chemistry |
Producer:Shandong Anhong Pharmaceutical Co., Ltd. (formerly Qilu Antibiotics (Linyi) Pharmaceutical Co., Ltd.) was incorporated in 2009 and is a subsidiary of Shandong Qilu Pharmaceutical Group Co., Ltd.
At present, the company has formed four series of chemical API production bases of cephalosporins, penem, anticancer and general drugs. Many product technical levels are at the international advanced level, and have passed the official certification at home and abroad, such as China GMP, the United States FDA, Japan PMDA, Germany GMP, South Korea KFDA, etc.
Staff size:1000-1999 persons
Registered capital:RMB 30 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE